From: Abstracts of 11th C1-inhibitor Deficiency & Angioedema Workshop
Country@ | Population 2018* | Estimated prevanlece 1:50,000 | Patients diagnosed | % With diagnosis |
---|---|---|---|---|
Argentina | 44,556,277 | 891 | 430 | 48.3 |
Brazil | 212,664,367 | 4,253 | 578 | 13.6 |
Chile | 18,433,065 | 368 | 11 | 2.98 |
Colombia | 49,436,892 | 989 | 227 | 22.9 |
Costa Rica | 4,945,674 | 99 | 19 | 19.1 |
Domincan Republic | 10,859,463 | 217 | 22 | 10.1 |
Ecuador | 16,783,322 | 335 | 5 | 1.49 |
El Salvador | 6,170,519 | 123 | 8 | 6.5 |
Guatemala | 17,206,382 | 344 | 3 | 0.87 |
Mexico | 131,452,016 | 2629 | 296 | 11.2 |
Panama | 4,092,816 | 82 | 13 | 15.8 |
Paraguay | 6,863,728 | 137 | 12 | 8.75 |
Peru | 32,424,843 | 648 | 15 | 2.31 |
Puerto Rico | 3,669,093 | 73 | 90 | 123 |
TOTAL | 559,558,457 | 11,188 | 1729 | 15.45 |